A 25-Year Quest to Restore Sight

What's happening

Molecular biologist Jean Bennett, ophthalmologist Albert Maguire, and physician Katherine A. High have won the $3 million Breakthrough Prize in Life Sciences for creating Luxturna, the first FDA-approved gene replacement therapy for a genetic disease. The therapy treats Leber congenital amaurosis, a rare inherited retinal condition that causes total blindness by early adulthood. It works by replacing a defective gene responsible for producing a protein critical to the visual cycle. The research began in the early 1990s. Luxturna was not approved until 2017. In between: animal models, adopted dogs whose sight was restored, and years of clinical trials at Children's Hospital of Philadelphia. Nearly all eligible patients in the United States with the relevant mutation have now been treated, and those treated over a decade ago maintain stable vision. The work has opened a wider field. More than 100 retinal gene therapy trials have followed. Twenty-five years of labor produced a single, specific cure, and that cure has held.

What the Text says

The most famous healing of blindness in Scripture is also the most misunderstood. In John 9, the disciples see a man born blind and ask the diagnostic question: who sinned?

John 9:1-31As he passed by, he saw a man blind from birth.2His disciples asked him, "Rabbi, who sinned, this man or his parents, that he was born blind?"3Jesus answered, "Neither did this man sin, nor his parents; but, that the works of God might be revealed in him.

Jesus refuses the framework entirely. The blindness is not a punishment to be explained. It is a condition through which something can be revealed. He then makes mud, applies it to the man's eyes, and sends him to wash. The healing is physical, specific, and slow. It requires the man's participation. It requires him to walk to the pool before he can see.

What readers often miss is the aftermath. The religious authorities interrogate the healed man repeatedly, not because they doubt the facts, but because the healing disrupts their categories. They know what blindness means in their theology. They do not know what to do with sight that arrives outside their system.

The text treats restored vision as a sign, something that points beyond itself. The cure matters. The body matters. And the meaning of the cure is not exhausted by the mechanism that produced it.

The reflection

Bennett began this work, by her own account, young and naive, not knowing what she didn't know. That is a particular kind of faith: fidelity to a problem you cannot yet solve. Twenty-five years is not a dramatic timeline. It is a mundane one, filled with failed experiments, grant applications, and dogs that needed walking. The breakthrough, when it came, did not erase the labor. It completed it. Scripture does not oppose sight and faith. It treats the restoration of sight as one of the clearest signs that God is at work in the physical world. Sometimes the evidence arrives on a long delay.